Proteomics was used to characterize phenotype of undifferentiated H9c2 cells.
Heart-derived H9c2 cells were found considerably different from cardiac myocytes.
Doxorubicin does not induce typical cardiotoxic proteomic signature in H9c2 cells.
Interpretation of findings obtained on H9c2 cells deserves caution and verification.